(NYSE: DGX) Quest Diagnostics's forecast annual revenue growth rate of 2.63% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Quest Diagnostics's revenue in 2024 is $9,287,000,000.On average, 9 Wall Street analysts forecast DGX's revenue for 2024 to be $1,043,563,029,424, with the lowest DGX revenue forecast at $1,039,080,595,504, and the highest DGX revenue forecast at $1,045,605,003,645. On average, 9 Wall Street analysts forecast DGX's revenue for 2025 to be $1,080,060,055,322, with the lowest DGX revenue forecast at $1,071,647,090,422, and the highest DGX revenue forecast at $1,099,489,527,248.
In 2026, DGX is forecast to generate $1,114,995,911,330 in revenue, with the lowest revenue forecast at $1,103,583,696,116 and the highest revenue forecast at $1,130,345,656,293.